VCNX
VACCINEX, INC.Company Information
- Company Name
- VACCINEX, INC.
- CIK
- CIK0001205922
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VCNX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VCNX
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-08-09
- Last sale
- 2023-12-26
- Shares purchased (TTM)
- 3,220,699
- Shares sold (TTM)
- 4,483
Institutional Sentiment
- As of
- 2024-12-31
- Institutional shares owned
- 53
- Shares outstanding
- 2,098,947
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2025-04-15
- Price on filing date
- —
- 1-month reaction
- -21.84%
- 3-month reaction
- -19.54%
Balance Sheet
Values in millions ($)| Line item | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 3 | 0 | 3 | 2 | 0 | 2 | 3 | 6 | 7 | 11 | 17 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 3 | 1 | 1 | 0 | - | 0 | 0 | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 3 | 5 | 2 | 7 | 3 | 2 | 3 | 4 | 7 | 8 | 12 | 18 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Derivative Assets Current | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 3 | 5 | 2 | 7 | 4 | 3 | 3 | 5 | 8 | 9 | 13 | 18 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 4 | 5 | 3 | 2 | 2 | 4 | 2 | 1 | 2 | 0 | 0 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 5 | 6 | 5 | 5 | 6 | 6 | 3 | 2 | 3 | 2 | 1 | 2 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Long Term Debt Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | - | - | - | - | ||||||
| Long Term Debt Noncurrent | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Liabilities | 5 | 6 | 5 | 5 | 6 | 6 | 4 | 2 | 3 | 2 | 2 | 2 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 2 | 2 | 1 | 1 | 0 | - | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 354 | 352 | 345 | 345 | 338 | 333 | 331 | 327 | 325 | 321 | 321 | 321 | ||||||
| Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -359 | -355 | -349 | -344 | -340 | -337 | -332 | -325 | -320 | -315 | -310 | -304 | ||||||
| Stockholders Equity | -2 | -1 | -3 | 3 | -2 | -4 | -0 | 2 | 5 | 6 | 11 | 16 | ||||||
| Liabilities And Stockholders Equity | 3 | 5 | 2 | 7 | 4 | 3 | 3 | 5 | 8 | 9 | 13 | 18 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 0 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Liquidation Preference Value | 1,750 | 1,750 | 1,750 | 1,750 | 0 | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 3 | 3 | 2 | 2 | 1 | 5 | 4 | 4 | 0 | 3 | 3 | 3 | ||||||
| Shares Outstanding | 3 | 3 | - | 2 | 1 | 5 | 4 | 4 | 0 | 3 | 3 | 3 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVACCINEX, INC. (VCNX) — SEC Financial Statements & Analysis
VACCINEX, INC. (VCNX) is a pharmaceutical preparations company, incorporated in DE. VACCINEX, INC. trades on OTC as: VCNX. VACCINEX, INC. (VCNX)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-04-15. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), VACCINEX, INC. carries a market cap of $2.06M, a P/E ratio of -0.11x, a P/B ratio of -0.83x, a P/S ratio of 3.42x, an enterprise value of $974.97K, and an EV/EBITDA multiple of -0.05x. On profitability, it posts an operating margin of -3117.30%, a net margin of -3100.50%, a Return on Equity (ROE) of 776.58%, and a Return on Assets (ROA) of -598.49%. Per share, it reports EPS of $-8.88, diluted EPS of $-8.88, free cash flow per share of $-7.72, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 5.44% year-over-year, net income growth of -7.98% year-over-year, and EPS growth of -79.67% year-over-year. On the balance sheet, it maintains a current ratio of 0.50x, a quick ratio of 0.38x, working capital of $-2.55M, a debt-to-equity ratio of -2.04x, a debt ratio of 1.96, an interest coverage ratio of -22973.00x, free cash flow of $-16.21M (TTM), and net debt of $-1.08M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.06M
- P/E TTM
- -0.11x
- EPS TTM
- $-8.88
- P/B TTM
- -0.83x
- ROE TTM
- 776.58%
- ROA TTM
- -598.49%
- Debt To Equity
- -2.04x
- Free Cash Flow TTM
- $-16.21M
- Net Revenue TTM Growth 1Y
- 5.44%
Data as of 2024-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VACCINEX, INC. in?
VACCINEX, INC. (VCNX) operates in the Pharmaceutical Preparations industry.
What exchange does VCNX trade on?
VACCINEX, INC. (VCNX) trades on the OTC.
Where is VACCINEX, INC. incorporated?
VACCINEX, INC. is incorporated in DE.
When was VACCINEX, INC. (VCNX)'s most recent SEC filing?
VACCINEX, INC. (VCNX)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-04-15.
What is VCNX's market cap?
VACCINEX, INC. (VCNX) has a market capitalization of $2.06M as of 2024-12-31.
What is VCNX's EPS (earnings per share)?
VACCINEX, INC. (VCNX)'s trailing twelve month EPS is $-8.88 as of 2024-12-31.
What is VCNX's ROE (return on equity)?
VACCINEX, INC. (VCNX)'s trailing twelve month Return on Equity (ROE) is 776.58% as of 2024-12-31.
What is VCNX's ROA (return on assets)?
VACCINEX, INC. (VCNX)'s trailing twelve month Return on Assets (ROA) is -598.49% as of 2024-12-31.
What is VCNX's EV/EBITDA?
VACCINEX, INC. (VCNX)'s trailing twelve month EV/EBITDA is -0.05x as of 2024-12-31.